With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.

Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but some physicians and rival Medtronic said more data is needed.

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing ...

Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Mindray is integrating Medtronic patient monitoring technologies into its platforms to meet the needs of ambulatory surgery centers.

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Integra LifeSciences has recalled wound and burn treatments over issues linked to 14 serious injuries, the Food and Drug ...

Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...